Microcytic Iron Deficiency Anemia In Neonates and Young Children: Current Diagnostic Approaches, Hematological Characteristics, Clinical Challenges, And Future Perspectives

Background: A major concern in public health, iron deficiency anemia affects the world's neonates, babies, and young children more than any other nutritional condition. Early-life populations are more vulnerable to iron deficiency due to their fast growth and elevated iron needs and can have significant impacts on physical growth, neurodevelopment and immune function. Clinical Significance: Untreated IDA is linked with poor cognitive functioning, delayed psychomotor development, behavioral disorders, increased susceptibility to infection, and diminished quality of life. It is therefore crucial to recognise and respond to a child's needs at an early stage to avoid permanent damage to their development. Epidemiology: IDA is a global problem affecting children to a greater extent than in middle- and low-income nations like India, with maternal anaemia, malnutrition, prematurity, low birth weight and poor complementary feeding as significant drivers of IDA. Public health efforts have had a long-term impact on IDA, but the disease continues to have a significant negative effect on health and social outcomes. Advances in Diagnosis: The diagnosis has shifted from classical hematological to biochemical and molecular diagnostics. New indicators of iron metabolism (such as soluble transferrin receptor, reticulocyte hemoglobin concentration, and hepcidin) complement traditional blood tests, peripheral blood smears, serum ferritin, and iron profiles, artificial intelligence (AI) based analysis, digital microscopy, and new point-of-care (POC) technologies have improved diagnosis accuracy and early detection. Hematological Characteristics: IDA is defined by reduced hemoglobin concentration, microcytosis, hypochromia, increased red cell distribution width, decreased serum ferritin and impaired erythropoiesis, representing progressive loss of body iron stores. Current Management and Future Directions: Management involves oral or intravenous iron supplementation, maternal nutrition optimisation, delayed cord clamping, diet modification, food fortification, and following international clinical guidelines. Future studies should seek to confirm new biomarkers, use AI in laboratory diagnosis, expand national screening programmes and promote the development of inexpensive precision diagnostic technologies to enhance early diagnosis and the outcome of children.